About Mesosil
Mesosil is a company based in Toronto (Canada) founded in 2016. Mesosil has raised $1.6 million across 2 funding rounds from investors including GreenSky Ventures and UTEST. Mesosil offers products and services including Mesosil™ 500. Mesosil operates in a competitive market with competitors including AFYREN, Spore Biotechnologies, Celsis, Biopsin and Source Molecular, among others.
- Headquarter Toronto, Canada
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.6 M (USD)
in 2 rounds
-
Latest Funding Round
$1.6 M (USD), Seed
Jun 14, 2024
-
Investors
GreenSky Ventures
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Mesosil
Mesosil offers a comprehensive portfolio of products and services, including Mesosil™ 500.
Enables sustained release of agents to prevent infections in medical applications.
Funding Insights of Mesosil
Mesosil has successfully raised a total of $1.6M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $1.6 million completed in June 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Mesosil
Mesosil has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include GreenSky Ventures and UTEST.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early stage Canadian B2B startups are funded by GreenSky Ventures.
|
Locked | Locked | Locked | |
|
Early-stage technology incubator is operated by University of Toronto.
|
Locked | Locked | Locked |
Investor details for Mesosil
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Mesosil
Investment portfolio details for Mesosil
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Mesosil
Detailed financials for Mesosil
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Mesosil Comparisons
Peer comparison for Mesosil
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Mesosil
Mesosil operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AFYREN, Spore Biotechnologies, Celsis, Biopsin and Source Molecular, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Analytical services are provided for microbiology, chemistry, and bioprocesses sectors.
|
|
| Locked | Locked | Locked |
Microbial detection technology is developed for life science industries.
|
|
| Locked | Locked | Locked |
Rapid microbial screening systems are manufactured for quality control testing.
|
|
| Locked | Locked | Locked |
Real-time microbial detection system is developed for product testing.
|
|
| Locked | Locked | Locked |
Technology for microbial source tracking is provided by Source Molecular.
|
Detailed competitors of Mesosil
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Mesosil
Complete news archive for Mesosil
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mesosil
Mesosil was founded in 2016.
Mesosil is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.
Mesosil is a funded company, having raised a total of $1.6M across 2 funding rounds to date.
Mesosil was founded in 2016 in Toronto, Canada, within the biotechnology sector. Antimicrobial materials are developed by the company to address infections at the medical device-tissue interface. These materials function as local antibacterial fillers based on self-assembled structures. Operations focus on applications such as dental restoratives and implant surfaces, supporting medical device enhancements in a regulated industry.
Mesosil's top competitors include AFYREN, Spore Biotechnologies and NCIMB.
Mesosil offers Mesosil™ 500.
Mesosil has 2 investors. Key investors include GreenSky Ventures, and UTEST.